Cormorant Asset Management, Llc

Affiliations

  • Other at Design Therapeutics Inc. (DSGN), 2021-04-01
  • Other at Prometheus Biosciences Inc. (RXDX), 2021-03-18
  • Other at Bioatla Inc. (BCAB), 2020-12-22
  • Other at Olema Pharmaceuticals Inc. (OLMA), 2020-11-23
  • Other at Atea Pharmaceuticals Inc. (AVIR), 2020-11-05
  • Other at Akouos Inc. (AKUS), 2020-07-02
  • Other at Avidity Biosciences Inc. (RNA), 2020-06-18
  • Other at Turning Point Therapeutics Inc. (TPTX), 2019-08-12
  • Large Shareholder at Axonics Modulation Technologies Inc. (AXNX), 2018-11-02
  • Large Shareholder at Constellation Pharmaceuticals Inc (CNST), 2018-07-20
  • Large Shareholder at Kezar Life Sciences Inc. (KZR), 2018-06-27
  • Large Shareholder at Kiniksa Pharmaceuticals Ltd. (KNSA), 2018-05-31
  • Large Shareholder at Proteostasis Therapeutics Inc. (PTI), 2017-12-18
  • Large Shareholder at Apellis Pharmaceuticals Inc. (APLS), 2017-11-14
  • Large Shareholder at Clearside Biomedical Inc. (CLSD), 2016-06-13
  • Large Shareholder at Cellectar Biosciences Inc. (CLRB), 2014-09-05
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
DSGN $20.00 750,000 Other 5,114,844 2021-03-30 Filing
RXDX $19.00 375,000 Other 2,223,022 2021-03-16 Filing
BCAB $18.00 800,000 Other 2,292,060 2020-12-18 Filing
OLMA $19.00 425,000 Other 3,270,544 2020-11-23 Filing
AKUS $17.00 290,000 Other 789,989 2020-06-30 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PTI $4.88 504,027 Large Shareholder 3,300,000 2017-12-14 Filing